Table I.

Correlation between STRN4 expression and clinicopathological parameters in patients with bladder transitional carcinoma.

		STRN4 expression
Clinical pathological variable	Number of patients	Low, n (%)	High, n (%)	P-value
Total	112	29 (25.9)	83 (74.1)
Age, years				0.542109
<65	35	12 (34.3)	23 (65.7)
≥65	77	22 (28.6)	55 (71.4)
Sex				0.240841
Male	81	36 (44.4)	45 (55.6)
Female	31	10 (32.3)	21 (67.7)
Tumor size, cm				0.005564
<3	82	31 (37.8)	51 (62.2)
≥3	30	6 (20.0)	24 (80.0)
Muscle infiltration				0.000357
Ta-I	23	14 (60.9)	9 (39.1)
T2-T4	89	20 (22.5)	69 (77.5)
Lymph node involvement				0.232024
No	100	46 (46.0)	54 (54.0)
Yes	12	5 (41.7)	7 (58.3)
Pathological tumor grade				0.001500
Low	42	18 (42.9)	24 (57.1)
High	70	11 (15.8)	59 (84.2)
Microvascular invasion				0.034741
No	47	17 (36.2)	30 (63.8)
Yes	65	12 (18.5)	53 (81.5)

STRN4, striatin-4; T, tumor.